Search Results 691-700 of 38876 for Two-phase

  1. Ibrutinib and Ixazomib Citrate in Treating Participants With Relapsed or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  3. Reishi Mushroom for Fatigue And/or Arthralgias for Patients With Breast Cancer on Aromatase Inhibitors - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. End-Stage Renal Disease Clinical Trials - Mayo Clinic Research

    ... two weeks after being interviewed and two weeks after receiving their SLD; to describe the investigators' growth in understanding the spirituality of ...

  5. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. A Study to Evaluate an Integrated Care Model Using Mobile Health Intervention in African American Patients with Hypertension - Mayo Clinic

    Health care provider (physician, registered nurse, physician assistant) at one of the two FQHCs. ... Phase 2. Diagnosis of a serious medical condition or ...

  7. Clinical Trial of Upfront Haploidentical or Unrelated Donor Bmt to Restore Normal Hematopoiesis in Aplastic Anemia

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection - Mayo Clinic

    Enrolled subjects will receive 2 planned RBX2660 enemas. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  10. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...